Wistar Melanoma Lines, 1977-present

Credit: courtesy of Trish Brafford" /> Credit: courtesy of Trish Brafford The human melanoma cell lines at the Wistar Institute in Philadelphia make up one of the most comprehensive collections of disease cell lines in the world. Since 1977, Meenhard Herlyn and his colleagues (click to read the related story A life behind life science) have collected samples from approximately 4,000 tumors, and esta

Written byElie Dolgin
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

The human melanoma cell lines at the Wistar Institute in Philadelphia make up one of the most comprehensive collections of disease cell lines in the world. Since 1977, Meenhard Herlyn and his colleagues (click to read the related story A life behind life science) have collected samples from approximately 4,000 tumors, and established more than 400 cell lines.

The collection grew out of a project to characterize the binding capacity of anti-melanoma antibodies to different tumor types. After seven failed attempts, the first cultured cell line, WM8, came from a large tumor in the groin of an elderly woman in 1977. The second successful line, WM9, from a metastatic lymph node, became the "workhorse" of melanoma research, says Herlyn, who estimates that over 800 pounds of this tumor have been grown in culture.

The WM cell lines are now routinely distributed free of charge to hundreds of labs worldwide. "There's ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies